✦ LIBER ✦

Thalidomide after lenalidomide: a possible treatment regimen in relapse refractory multiple myeloma patients

✍ Scribed by Tommasina Guglielmelli; Maria Teresa Petrucci; Giuseppe Saglio; Antonio Palumbo

Book ID: 108677001
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 98 KB
Volume: 152
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08416.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lenalidomide plus dexamethasone treatmen

Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma

✍ Shinsuke Iida; Takaaki Chou; Shinichiro Okamoto; Hirokazu Nagai; Kiyohiko Hatake 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 333 KB

Prolonged treatment with lenalidomide in

Prolonged treatment with lenalidomide in relapsed and refractory multiple myeloma

✍ Carlos Aguilar Franco; Luis Palomera; Jose Joaquín Ruiz Arredondo; Jesús Martín 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 499 KB

Erratum to: Lenalidomide plus dexamethas

Erratum to: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma

✍ Shinsuke Iida; Takaaki Chou; Shinichiro Okamoto; Hirokazu Nagai; Kiyohiko Hatake 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 111 KB

Lenalidomide in combination with dexamet

Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment

✍ Ulrike Klein; Kai Neben; Thomas Hielscher; Christiane Heiß; Anthony D. Ho; Hartm 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 204 KB

Bortezomib in combination with thalidomi

Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma

✍ Dominik Dytfeld; Magdalena Matuszak; Krzysztof Lewandowski; Mieczysław Komarnick 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 84 KB

Combined thalidomide and cyclophosphamid

Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study

✍ Sjoerd Hovenga; Simon M. G. J. Daenen; Joost T. M. de Wolf; Gustaaf W. van Imhof 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 118 KB